246 related articles for article (PubMed ID: 31590236)
1. Photobiomodulation Mitigates Cerebrovascular Leakage Induced by the Parkinsonian Neurotoxin MPTP.
San Miguel M; Martin KL; Stone J; Johnstone DM
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31590236
[TBL] [Abstract][Full Text] [Related]
2. Pre-conditioning with Remote Photobiomodulation Modulates the Brain Transcriptome and Protects Against MPTP Insult in Mice.
Ganeshan V; Skladnev NV; Kim JY; Mitrofanis J; Stone J; Johnstone DM
Neuroscience; 2019 Feb; 400():85-97. PubMed ID: 30625333
[TBL] [Abstract][Full Text] [Related]
3. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
4. Remote tissue conditioning is neuroprotective against MPTP insult in mice.
Kim B; Mitrofanis J; Stone J; Johnstone DM
IBRO Rep; 2018 Jun; 4():14-17. PubMed ID: 30135947
[TBL] [Abstract][Full Text] [Related]
5. Remote photobiomodulation targeted at the abdomen or legs provides effective neuroprotection against parkinsonian MPTP insult.
Gordon LC; Martin KL; Torres N; Benabid AL; Mitrofanis J; Stone J; Moro C; Johnstone DM
Eur J Neurosci; 2023 May; 57(9):1611-1624. PubMed ID: 36949610
[TBL] [Abstract][Full Text] [Related]
6. Photobiomodulation-induced changes in a monkey model of Parkinson's disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatum.
El Massri N; Lemgruber AP; Rowe IJ; Moro C; Torres N; Reinhart F; Chabrol C; Benabid AL; Mitrofanis J
Exp Brain Res; 2017 Jun; 235(6):1861-1874. PubMed ID: 28299414
[TBL] [Abstract][Full Text] [Related]
7. Photobiomodulation preserves behaviour and midbrain dopaminergic cells from MPTP toxicity: evidence from two mouse strains.
Moro C; Torres N; El Massri N; Ratel D; Johnstone DM; Stone J; Mitrofanis J; Benabid AL
BMC Neurosci; 2013 Mar; 14():40. PubMed ID: 23531041
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice.
Shi X; Chen YH; Liu H; Qu HD
Mol Med Rep; 2016 Sep; 14(3):2397-404. PubMed ID: 27484986
[TBL] [Abstract][Full Text] [Related]
10. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
[TBL] [Abstract][Full Text] [Related]
11. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinson's disease mouse model: Endothelial and microglial effects.
Burks S; Raymick J; Robinson B; Hanig J; Sarkar S
Neurosci Lett; 2019 Jun; 703():86-95. PubMed ID: 30890473
[TBL] [Abstract][Full Text] [Related]
13. Protective role of 6-Hydroxy-1-H-Indazole in an MPTP-induced mouse model of Parkinson's disease.
Xiao-Feng L; Wen-Ting Z; Yuan-Yuan X; Chong-Fa L; Lu Z; Jin-Jun R; Wen-Ya W
Eur J Pharmacol; 2016 Nov; 791():348-354. PubMed ID: 27614126
[TBL] [Abstract][Full Text] [Related]
14. Modulation of mitochondrial phenotypes by endurance exercise contributes to neuroprotection against a MPTP-induced animal model of PD.
Jang Y; Kwon I; Song W; Cosio-Lima LM; Taylor S; Lee Y
Life Sci; 2018 Sep; 209():455-465. PubMed ID: 30144449
[TBL] [Abstract][Full Text] [Related]
15. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
[TBL] [Abstract][Full Text] [Related]
17. [The comparison of neurobehavioral changes and impaired locations between the mouse model of manganism and Parkinson's disease].
Dou CS; Zhi CN; Liu WL; Fu JL; Yao BY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Feb; 36(2):84-90. PubMed ID: 29699003
[No Abstract] [Full Text] [Related]
18. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
19. Pain perception in acute model mice of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Park J; Lim CS; Seo H; Park CA; Zhuo M; Kaang BK; Lee K
Mol Pain; 2015 May; 11():28. PubMed ID: 25981600
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
